Patent 12076583 was granted and assigned to Alpha Tau Medical on September, 2024 by the United States Patent and Trademark Office.
A method for treating a tumor, comprising identifying a tumor as a melanoma tumor and implanting in the tumor identified as a melanoma tumor, at least one diffusing alpha-emitter radiation therapy (DaRT) source (